ES8802117A1 - Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas - Google Patents

Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas

Info

Publication number
ES8802117A1
ES8802117A1 ES541955A ES541955A ES8802117A1 ES 8802117 A1 ES8802117 A1 ES 8802117A1 ES 541955 A ES541955 A ES 541955A ES 541955 A ES541955 A ES 541955A ES 8802117 A1 ES8802117 A1 ES 8802117A1
Authority
ES
Spain
Prior art keywords
vaccine
negative bacteria
preparing
against gram
immunization against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES541955A
Other languages
English (en)
Other versions
ES541955A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Missouri Columbia
University of Missouri St Louis
Original Assignee
University of Missouri Columbia
University of Missouri St Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Missouri Columbia, University of Missouri St Louis filed Critical University of Missouri Columbia
Publication of ES8802117A1 publication Critical patent/ES8802117A1/es
Publication of ES541955A0 publication Critical patent/ES541955A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

METODO PARA PREPARAR UNA VACUNA EN QUE SE COMBINAN UNA SUSPENSION MUERTA DE SALMONELLA ENTERITIDIS COMO MUTANTE BACTERIANO CON UN MODULADOR INMUNE SELECCIONADO DEL GRUPO LIPIDO A NO TOXICO, ENDOTOXINA DESTOXIFICADA Y ENDOTOXOIDE. DICHA COMBINACION SE PONE EN SUSPENSION EN UN VEHICULO FIJADOR DE PROTEINAS Y LIPIDOS SELECCIONADO DEL GRUPO CONSTITUIDO POR ACIDOS Y COADYUVANTES A BASE DE ACEITES Y DE ALUMBRE, PREFERIBLEMENTE EN 1,5% EN VOLUMEN DE TRIOXIDO DE DIALUMINIO, PARA ABSORBER EL RESTO DEL MODULADOR INMUNE. TIENE APLICACION COMO MEDICAMENTO PARA TRATAR ENFERMEDADES PRODUCIDAS POR BACTERIAS GRAM-NEGATIVAS.
ES541955A 1984-04-05 1985-04-03 Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas Expired ES8802117A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59711584A 1984-04-05 1984-04-05
US69700885A 1985-01-31 1985-01-31

Publications (2)

Publication Number Publication Date
ES8802117A1 true ES8802117A1 (es) 1988-04-01
ES541955A0 ES541955A0 (es) 1988-04-01

Family

ID=27082733

Family Applications (2)

Application Number Title Priority Date Filing Date
ES541955A Expired ES8802117A1 (es) 1984-04-05 1985-04-03 Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas
ES550947A Expired ES8802118A1 (es) 1984-04-05 1986-01-16 Un metodo para preparar un modulador inmune a base de un lipolisacarido bacteriano dextoxificado.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES550947A Expired ES8802118A1 (es) 1984-04-05 1986-01-16 Un metodo para preparar un modulador inmune a base de un lipolisacarido bacteriano dextoxificado.

Country Status (10)

Country Link
US (2) US5641492A (es)
EP (2) EP0158282B1 (es)
JP (3) JP2625099B2 (es)
AR (1) AR242903A1 (es)
AU (2) AU589552B2 (es)
CA (1) CA1263306A (es)
DE (1) DE3587681T2 (es)
ES (2) ES8802117A1 (es)
IE (1) IE940698L (es)
PH (1) PH23104A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
EP0209554A4 (en) * 1985-01-15 1988-03-22 Unisearch Ltd Immunoassay systems for the detection of salmonella.
FI871174L (fi) * 1986-03-18 1987-09-19 Research Corp Foerfarande foer bestaemning av haptener med hjaelp av immunoanalysteknik.
ZA873698B (en) * 1986-05-23 1987-11-18 Midcon Labs, Inc. Co-vaccination using non-o-carbohydrate side-chain gram-negative bacteria preparation
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US6887483B2 (en) * 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria
WO1998053851A1 (en) * 1997-05-28 1998-12-03 University Of Iowa Research Foundation Laft mutants of pathogenic gram-negative bacteria
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
EP1023903B1 (en) * 1999-01-26 2004-01-14 Akzo Nobel N.V. Use of life attenuated bacteria for the manufacture of a submucosal vaccine
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US6379676B2 (en) * 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
WO2006130161A2 (en) * 2004-07-21 2006-12-07 The Cornell Research Foundation, Inc. Therapeutic compounds derived from spider venom and their method of use
WO2011092185A1 (en) 2010-01-28 2011-08-04 Universiteit Gent Salmonella vaccine
EP3185896B1 (en) 2014-06-20 2025-04-02 University of Saskatchewan Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
CA3208643A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB164622A (en) * 1920-06-11 1921-06-16 C L I Mfg Company Ltd Improvements in lamp and other brackets for use on cycles and motor cycles
US3075883A (en) * 1961-11-08 1963-01-29 Cons Lab Inc Novel parenteral vaccine antigen compositions and methods of making and using
US4029762A (en) * 1971-11-17 1977-06-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Lipid A-preparation
GB1560934A (en) * 1975-05-07 1980-02-13 Unilever Ltd Methods for the resistance of non-human mammals to gastro-intestinal disorders
US4148877A (en) * 1975-12-29 1979-04-10 Choay S. A. Fraction capable of inducing in vivo a resistance to bacterial infections, process for obtaining said fraction from bacteria and drugs containing said fraction
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4567041A (en) * 1977-12-08 1986-01-28 Likhite Vilas V Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
US4530832A (en) * 1978-12-07 1985-07-23 Schering Corporation Method of vaccination for prevention of Bordetella bronchiseptica infection
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
US4327082A (en) * 1979-07-12 1982-04-27 Adcock-Ingram Laboratories Limited Mastitis vaccination
AU529322B2 (en) * 1979-07-27 1983-06-02 Pitman-Moore, Inc. Antigenic compositions
FR2464300B1 (fr) * 1979-08-29 1983-08-05 Agronomique Inst Nat Rech Preparation de souches salmonella abortus ovis et compositions de vaccins les contenant
US4491660A (en) * 1980-01-10 1985-01-01 Abbott Laboratories Matrix polymers for binding endotoxins
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US4328210A (en) * 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DE3022914A1 (de) * 1980-06-19 1981-12-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zurgewinnung eines anaphylatoxin und cocytotaxin enthaltenden leukotaxinpraeparates sowie von anaphylatoxin und cocytotaxin in molekular einheitlicher form
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4582790A (en) * 1983-02-15 1986-04-15 Wisconsin Alumni Research Foundation Monoclonal antibody to angiotension-converting enzyme and methods of preparing and using same
GB8305323D0 (en) * 1983-02-25 1983-03-30 Baylor College Medicine Infectious bovine rhinotracheitis vaccine
US4571336A (en) * 1983-08-25 1986-02-18 Endorphin, Inc. Immune stimulation
US4762712A (en) * 1983-08-31 1988-08-09 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation

Also Published As

Publication number Publication date
ES8802118A1 (es) 1988-04-01
EP0158282B1 (en) 1993-12-15
JPS6121A (ja) 1986-01-06
ES550947A0 (es) 1988-04-01
JP2625099B2 (ja) 1997-06-25
US5641492A (en) 1997-06-24
AU634972B2 (en) 1993-03-11
JP2534032B2 (ja) 1996-09-11
JPH07250673A (ja) 1995-10-03
AR242903A1 (es) 1993-06-30
AU589552B2 (en) 1989-10-19
PH23104A (en) 1989-04-10
AU4076785A (en) 1985-10-10
ES541955A0 (es) 1988-04-01
IE940698L (en) 1985-10-05
JP2638755B2 (ja) 1997-08-06
EP0158282A3 (en) 1988-05-25
DE3587681D1 (de) 1994-01-27
US5961985A (en) 1999-10-05
DE3587681T2 (de) 1994-07-07
EP0540063A1 (en) 1993-05-05
JPH07252165A (ja) 1995-10-03
EP0158282A2 (en) 1985-10-16
AU3910689A (en) 1989-11-23
CA1263306A (en) 1989-11-28

Similar Documents

Publication Publication Date Title
ES8802117A1 (es) Un metodo para preparar una vacuna para inmunizacion contra enfermedades por bacterias gram-negativas
Silverstein et al. Fetal Response to Antigenic Stimulus: III. γ-Globulin Production in Normal and Stimulated Fetal Lambs
EP0692031A4 (en) HETEROLOGIST ANTIGENES IN STRAINS FOR VACCINATION WITH LIVING CELLS
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
ES2006925A6 (es) Procedimiento para la preparacion de vectores de expresion.
NO20004972D0 (no) Derivater av pneumokokkiske kolinbindende proteiner
DE68924162D1 (de) Stressproteine und verwendungen dafür.
LV12085A (lv) Dendritiskas sunas stimulejosais faktors
ES8802209A1 (es) Procedimiento de acondicionar preparados de vacunas inyectables a animales.
CA2134835A1 (en) Live in ovo vaccine
EP0722338A4 (en) Vaccines consisting of protein or peptide "cochlates" and their use for immunization
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
ES2160601T3 (es) Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
Specter et al. Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide
AR039982A1 (es) Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas
DE69030099D1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
ES8302086A1 (es) Un procedimiento para preparar vacunas de pasteurella multocida y pasteunella haemolytica vivas modificadas con efectos veterinarios, particularmente para especies de animales bovinos, porcinos y ovinos.
Jarrett et al. The effect of various adjuvant regimens and of nematode infection on the reaginic antibody response to egg-albumin in the rat
Smadel Intracellular Infection and the Carrier State: The path of clinical investigation leads from bench to bed and back again.
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
IE921832A1 (en) Fish vaccine
Brown et al. Fowl Cholera Immunization in Turkeys: I. Efficacy of Various Cell Fractions of Pasteurella multocida as Vaccines
Rasmussen Evidence for the presence of a K antigen in strains of Vibrio anguillarum
Cypess et al. Macrophage inhibition produced by guinea pigs after sensitization with a larval antigen of Trichinella spiralis
RU94036809A (ru) Инактивированная вакцина против сальмонеллеза овец

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20151230